Progressive Care
Logotype for Progressive Care Inc

Progressive Care (RXMD) investor relations material

Progressive Care has been private

Progressive Care Q2 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Progressive Care Inc
Q2 2024 earnings summary14 Aug, 2024

Executive summary

  • Q2 2024 revenue increased 17% year-over-year to $13.5 million, driven by higher prescription and 340B contract revenue.

  • Gross profit margin improved to 35% from 31% in the prior year quarter, reflecting better reimbursement rates and higher prescription volumes.

  • Net loss for Q2 2024 was $9.3 million, mainly due to $9.8 million in impairment losses for goodwill and intangible assets.

  • The company operates two segments: Pharmacy Operations and Third-Party Administration (TPA).

  • Positive cash flow from operations was achieved, with a cash balance of $8.5 million as of June 30, 2024.

Financial highlights

  • Q2 2024 revenues: $13.5M (Q2 2023: $11.6M); 6M 2024 revenues: $28.1M (6M 2023: $22.9M).

  • Prescription revenue, net of PBM fees, rose 11% to $10.5M; 340B contract revenue grew 41% to $3.0M.

  • Gross profit for Q2 2024: $4.7M (Q2 2023: $3.6M); gross margin 35% (Q2 2023: 31%).

  • Operating expenses for Q2 2024: $14.0M (Q2 2023: $2.9M), including $9.8M in impairment losses.

  • Net loss was $9.3M, compared to $4.6M in Q2 2023.

Outlook and guidance

  • Management expects current cash position and operating cash flow to support obligations for at least 12 months.

  • Merger with NextPlat expected to close in early October 2024, pending shareholder approval, with anticipated cost reductions and expanded services.

  • Revenue growth is expected from expanding pharmacy services, new drugs, and additional 340B contracts.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Progressive Care
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Progressive Care Inc. is a healthcare services company that provides prescription pharmaceuticals, compounded medications, and telepharmacy services. The company operates through its subsidiary, PharmCo, which offers traditional and specialty pharmacy services, including medication therapy management, health risk assessments, and adherence monitoring. Progressive Care focuses on improving patient care through personalized pharmaceutical services, serving patients with complex chronic conditions. Additionally, the company leverages technology to provide telehealth solutions, allowing for remote patient consultations and prescription management. The company is headquartered in Hallandale Beach, Florida, and its shares are listed on the OTCQB.